120 related articles for article (PubMed ID: 4005128)
1. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
[TBL] [Abstract][Full Text] [Related]
2. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
Grainger SL; John VA; Shotton PA; Smith SE
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
[TBL] [Abstract][Full Text] [Related]
3. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
[TBL] [Abstract][Full Text] [Related]
6. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
[TBL] [Abstract][Full Text] [Related]
10. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
[TBL] [Abstract][Full Text] [Related]
11. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
[TBL] [Abstract][Full Text] [Related]
13. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
Bauer K; Rakusan S; Kaik G
Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
[TBL] [Abstract][Full Text] [Related]
15. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
[TBL] [Abstract][Full Text] [Related]
16. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
Richard J; Cardot JM; Godbillon J
Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
Oosterhuis B; Jonkman JH; Kerkhof FA
Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
[TBL] [Abstract][Full Text] [Related]
18. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
19. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
Freestone S; Lennard MS; Silas JH; Ramsay LE
Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
